Compare CMND & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMND | FGNX |
|---|---|---|
| Founded | 2017 | 1932 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.1M |
| IPO Year | N/A | N/A |
| Metric | CMND | FGNX |
|---|---|---|
| Price | $0.07 | $2.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 22.7M | 980.0K |
| Earning Date | 01-21-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,450,000.00 |
| Revenue This Year | N/A | $88.77 |
| Revenue Next Year | N/A | $43.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 144.71 |
| 52 Week Low | $0.07 | $2.30 |
| 52 Week High | $2.18 | $41.25 |
| Indicator | CMND | FGNX |
|---|---|---|
| Relative Strength Index (RSI) | 15.25 | N/A |
| Support Level | $0.07 | N/A |
| Resistance Level | $0.13 | N/A |
| Average True Range (ATR) | 0.02 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 6.01 | 0.00 |
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.